Steve Closter
Chief Commercial Officer
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Syndax Pharmaceuticals Inc (SNDX) | Chief Commercial Officer | $485,300 | $2,125,887 |
| 2024 | Syndax Pharmaceuticals Inc (SNDX) | Chief Commercial Officer | $364,167 | $3,557,137 |
Earnings-call appearances
-
Syndax Pharmaceuticals Inc Q2 FY2026 Earnings Call2026-08-04
Syndax Pharmaceuticals Inc (SNDX)
-
Syndax Pharmaceuticals Inc Q3 FY2025 Earnings Call2025-11-03
Syndax Pharmaceuticals Inc (SNDX)
-
Syndax Pharmaceuticals Inc Q2 FY2025 Earnings Call2025-08-04
Syndax Pharmaceuticals Inc (SNDX)
-
Syndax Pharmaceuticals Inc Q1 FY2025 Earnings Call2025-05-05
Syndax Pharmaceuticals Inc (SNDX)
-
Syndax Pharmaceuticals Inc Q4 FY2024 Earnings Call2025-03-03
Syndax Pharmaceuticals Inc (SNDX)
-
Syndax Pharmaceuticals Inc Q3 FY2024 Earnings Call2024-11-05
Syndax Pharmaceuticals Inc (SNDX)
-
Syndax Pharmaceuticals Inc Q2 FY2024 Earnings Call2024-08-01
Syndax Pharmaceuticals Inc (SNDX)
-
Syndax Pharmaceuticals Inc Q1 FY2024 Earnings Call2024-05-08
Syndax Pharmaceuticals Inc (SNDX)